Skip to main content

SMBC Venture Capital — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

582
Companies
$7.2B
Total invested
$16.7M
Avg. check
65
Industries
Biotechnology 5Manufacturing 4Health Care 4Software 3Sales 3Artificial Intelligence (AI) 3+59 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 49–72 of 582
LIFESCAPES
July 2026

LIFESCAPES develops Brain-Machine Interface technology to support rehabilitation for patients with severe paralysis following strokes.

Manufacturing · Tokyo$307K Grant
Etaily
July 2026

Etaily provides brands with end-to-end omni-channel eCommerce solutions.

E-Commerce · Singapore$17.8M Venture - Series Unknown
Newmo
July 2025

Newmo develops ride-sharing service platform designed to provide a means of transport to local communities and consumers.

B2C · Tokyo$8.4M Series A
OPTEMO
July 2025

OPTEMO develops and supplies sales technology that allows businesses and customers to connect through a website.

Information Technology · Tokyo$3.5M Venture - Series Unknown
Sazo
July 2026

Sazo develops and operates an AI-powered cross-border e-commerce platform that facilitates international shopping and purchasing services.

Artificial Intelligence (AI) · Nagoya$10.2M Series A
Idein
July 2025

Idein is a technology company that enables real-world events to be processed and managed by software.

Artificial Intelligence (AI) · TokyoVenture - Series Unknown
Alumnote
July 2025

Alumnote develops online alumni association management platforms that enable schools to manage their alumni associations and alumni.

Alumni · Tokyo$5.2M Series A
DayBreak
July 2023

DayBreak is a food technology enterprise that provides freezing solutions and specializes in the distribution of frozen food products.

Food and Beverage · Tokyo$14.4M Series B
Link Therapeutics
July 2025

Link Therapeutics specializes in developing therapeutic methods for targeting autoantibodies and identifying pathogenic autoantibodies.

Emergency Medicine · Kyoto$5.7M Series B
ROXX
July 2024

ROXX platform focuses on recruiting inexperienced full-time employees with features of reference compliance and research tools.

Artificial Intelligence (AI) · Tokyo$7.6M Secondary Market
Nudge
July 2026

Nudge is a fintech company that provides innovative credit card services and builds future-focused financial experiences.

Credit Cards · Tokyo$9.1M Venture - Series Unknown
Thinker
July 2025

Thinker is a technology company that specializes in the sales of proximity sensors and offers proposed solutions using these products.

Manufacturing · Tokyo$3.5M Venture - Series Unknown
Suit Up
July 2024

Suitup is a project and task management solution.

Marketing · Tokyo$1.2M Seed
AlgaleX
July 2026

AlgaleX is a biotechnology company that develops AI-powered algae fermentation technology to produce sustainable food ingredients.

Alternative Protein · Uruma$2.2M Series A
Brainbuddy
June 2025

Brainbuddy specializes in sales support, business growth, recruiting, consulting, and training services.

Consulting · Tokyo$5.5M Series B
Modalis Therapeutics
June 2025

Modalis is a biotech company that develops therapeutics using CRISPR based technology.

Biotechnology · TokyoPost-IPO Equity
Nekonome
June 2026

Nekonome creates a game platform with global character designs, in-game updates, and regular events.

Gaming · Tokyo$687K Series A
Letara
June 2025

Letara is an aerospace component manufacturing company that produces hybrid propulsion engines for small spacecraft.

Aerospace · SapporoSeed
Cellusion
June 2023

Cellusion is a biotechnology research firm that focuses on corneal endothelial regenerative medicine intended to improve eye vision.

Biotechnology · Tokyo$20.3M Series C
LUCA Science
June 2022

LUCA Science develops innovative treatments intended for mitochondrial and related diseases.

Biotechnology · Tokyo$29.2M Series B
YeLL
June 2024

YeLL is a company that help transform the organization by making the real sound of employees visible.

Recruiting · Tokyo$2.1M Series B
Neusignal Therapeutics
June 2026

Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.

Biotechnology · Tokyo$32.8M Series B
Morus
June 2025

Morus is a food technology firm that specializes in the research and development of sustainable protein and new food alternatives.

Alternative Protein · Tokyo$5.0M Series A
ROUTE06
June 2022

ROUTE06 empowers product builders with AI and expertise to turn ideas into innovative, scalable digital experiences.

B2B · Marunouchi$11.0M Series A

Where SMBC Venture Capital invests

Biotechnology5
Manufacturing4
Health Care4
Software3
Sales3
Artificial Intelligence (AI)3

About SMBC Venture Capital's portfolio

How many companies has SMBC Venture Capital invested in?▸

SMBC Venture Capital has invested in 582 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does SMBC Venture Capital invest in?▸

SMBC Venture Capital's top investment sectors include Biotechnology, Manufacturing, Health Care, Software, Sales. The firm invests across 65 different industry categories.

What is SMBC Venture Capital's largest investment?▸

Among tracked funding rounds, Neusignal Therapeutics received $32.8M in a Series B round. SMBC Venture Capital's total known invested capital is $7.2B.

What is the average investment size for SMBC Venture Capital?▸

SMBC Venture Capital's average investment size is $16.7M across its portfolio of 582 companies.

What are SMBC Venture Capital's most recent investments?▸

Recent SMBC Venture Capital portfolio additions include LIFESCAPES, Etaily, Newmo, OPTEMO, Sazo. These companies were founded in 2020 or later.

Reach the founders behind these 582 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →